Oramed Pharmaceuticals Inc. (ORMP) quarterly cash flow statement — complete operating, investing & financing history
Oramed Pharmaceuticals Inc. (ORMP) cash flow statement — 22-year operating, investing & financing cash flows
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Cash from Operations | -200K | -2.92M | -466K | -1.99M | -3.57M | -3.52M | -1.94M | -7.07M | 2.07M | -1.48M | -1.34M | -545.64K | -2.5M | -5.55M | -7.62M | -2.13M | -8.08M | -9.8M | -6.9M | -6.28M |
| Operating CF Margin % | - | - | - | - | - | -175.95% | - | - | - | - | - | - | -371.29% | -833.18% | -1119.16% | -312.7% | -1198.43% | -1471.77% | -1024.18% | -919.11% |
| Operating CF Growth % | 94.4% | 17.16% | 75.92% | 71.9% | -272.33% | -138.41% | -44.8% | -1195.87% | 182.76% | 73.4% | 82.46% | 74.41% | 69.02% | 43.39% | -10.41% | 66.03% | -44.74% | -183.21% | -12.21% | -122.85% |
| Net Income | 78.16M | 38.31M | 10.01M | 48.4M | 13.29M | -7.64M | -10.19M | -19.62M | 9.21M | 1.54M | 13.34M | -3.22M | -1.19M | -3.4M | -8.54M | -7.06M | -10.53M | -10.43M | -8.1M | -6.85M |
| Depreciation & Amortization | 31K | 30K | 30K | 31K | 30K | 30K | 31K | 52K | 54K | 56K | 53K | 54K | 52K | 37K | 17K | 15K | 15K | 11K | 12K | 19K |
| Stock-Based Compensation | 1.39M | 0 | 2.28M | 0 | 0 | 2.19M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.71M | 0 |
| Deferred Taxes | 21.8M | 0 | -10K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -103.5M | -49.08M | -13.43M | -60.26M | -14.23M | 3.48M | 8.2M | 10.87M | -9.36M | -2.44M | -14.3M | 798.89K | 1.82M | -1.38M | 2.4M | 2.53M | 2.12M | 2.72M | -232K | 451.84K |
| Working Capital Changes | 1.92M | 7.82M | 649K | 9.84M | -2.66M | -1.57M | 27.03K | 1.63M | 2.17M | -626K | -428.14K | 1.82M | -3.18M | -816K | -1.5M | 2.38M | 320.35K | -2.11M | -295K | 104.62K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -149K | 149K | 1.74M | 2.66M | -3.11M | -185K | 440.65K | 1.55M | 2.2M | -666K | -596.4K | 1.72M | -3.17M | -103K | -42.04K | 710.25K | 120.77K | -1.15M | 981K | 944.58K |
| Cash from Investing | 4.31M | -19.49M | -1.68M | 38.84M | -55M | 23.62M | 15.76M | -33.59M | 93.63M | 30M | 29.31M | -72.32M | -14.26M | -13.2M | 10.71M | 1.05M | 9.96M | 7.36M | -99.05M | -27.91M |
| Capital Expenditures | -2K | -5K | 202K | -285 | -4.03K | -3K | -11.03K | -4.99K | 16 | -2K | -2K | -27.61K | -16.48K | -199K | -295.26K | -116.8K | -18.49K | -47K | 0 | -28.56K |
| CapEx % of Revenue | - | - | - | - | - | 0.15% | - | - | - | - | - | - | 2.45% | 29.88% | 43.36% | 17.13% | 2.74% | 7.06% | - | 4.18% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23.11K | 0 | 0 | 0 | 0 | 1.52M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -2K | -11.92M | 0 | -266.73K | -1.96M | 0 | -64.97K | 22 | 4.96K | 0 | 0 | 0 | 0 | 0 | -983 | -23 | 2.93K | 0 | -1K | -3 |
| Cash from Financing | -1.95M | -10.36M | -4.01M | -392.62K | -372.79K | 0 | -1.39M | -1.5M | -30.14M | -19M | -24.4M | 72.16M | -39.05K | 2.43M | 3.97M | 4.26M | -67.95K | 2.97M | 60.56M | 54.42M |
| Debt Issued (Net) | 0 | -10.36M | 0 | 0 | 0 | 0 | -187.18K | -213.71K | -30.14M | -19M | -24.39M | 72.2M | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | 0 | 0 | -4.01M | -392.62K | -372.79K | 0 | -1.2M | -1.29M | 0 | 0 | -8.65K | -39.49K | -39.05K | 2.43M | 3.97M | 4.26M | -67.95K | 2.97M | - | 54.42M |
| Dividends Paid | -78K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | -4.01M | -392.62K | -372.79K | 0 | -1.2M | -1.29M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -1.87M | 0 | 0 | 0 | 0 | 0 | -2K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 623K | 0 |
| Net Change in Cash | 2.04M | -32.74M | -6.23M | 36.38M | -58.72M | 20.1M | 12.32M | -42.65M | 66.18M | 9.52M | 3.59M | -1.3M | -17.34M | -16.36M | 7.27M | 3.3M | 1.93M | -49.28M | -45.37M | 19.83M |
| Free Cash Flow | -202K | -2.92M | -264K | -1.99M | -3.57M | -3.52M | -1.95M | -7.08M | 2.07M | -1.48M | -1.34M | -573.25K | -2.52M | -5.75M | -7.92M | -2.25M | -8.1M | -9.85M | -6.9M | -6.31M |
| FCF Margin % | - | - | - | - | - | -176.1% | - | - | - | - | - | - | -373.74% | -863.06% | -1162.52% | -329.83% | -1201.17% | -1478.83% | -1024.18% | -923.29% |
| FCF Growth % | 94.35% | 17.09% | 86.44% | 71.91% | -272.52% | -138.29% | -45.4% | -1134.34% | 182.22% | 74.29% | 83.09% | 74.52% | 68.89% | 41.64% | -14.69% | 64.33% | -45.13% | -181.25% | -6.77% | -117.65% |
| FCF per Share | -0.00 | -0.07 | -0.01 | -0.05 | -0.08 | -0.09 | -0.05 | -0.17 | 0.05 | -0.04 | -0.03 | -0.01 | -0.06 | -0.14 | -0.20 | -0.06 | -0.21 | -0.25 | -0.19 | -0.21 |
| FCF Conversion (FCF/Net Income) | -0.00x | -0.08x | -0.05x | -0.04x | -0.27x | 0.46x | 0.19x | 0.36x | 0.22x | -0.96x | -0.10x | 0.17x | 2.10x | 3.09x | 0.89x | 0.29x | 0.77x | 0.94x | 0.87x | 0.92x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.75M | 571K | 0 | - | - | - | - | - | - | - | - | - |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -14K | - | - | - | - | - | - | - | - | - |